Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma

ClinicalTrials.gov ID: NCT01730027

Public ClinicalTrials.gov record NCT01730027. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomised, Double Blind, Placebo-Controlled, Multi-Centre, Parallel Group Study to Evaluate the Efficacy and Safety of ADC3680 Administered Once Daily as an Add-On Therapy to Inhaled Corticosteroids and When Co-Administered With Montelukast in Subjects With Inadequately-Controlled Asthma.

Study identification

NCT ID
NCT01730027
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pulmagen Therapeutics
Industry
Enrollment
248 participants

Conditions and interventions

Conditions

Interventions

  • ADC3680 Drug
  • Placebo Drug
  • montelukast Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2013
Primary completion
Nov 30, 2014
Completion
Nov 30, 2014
Last update posted
Oct 5, 2017

2013 – 2014

United States locations

U.S. sites
35
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
Pulmagen Investigational Site Birmingham Alabama
Pulmagen Investigational Site Huntington Beach California 922647
Pulmagen Investigational Site Riverside California
Pulmagen Investigational Site Rolling Hills California 90274
Pulmagen Investigational Site San Jose California
Pulmagen Investigational Site Colorado Springs Colorado
Pulmagen Investigational Site Waterbury Connecticut 6708
Pulmagen Investigational Site Lawrenceville Georgia 30046
Pulmagen Investigational Site Eagle Idaho 83616
Pulmagen Investigational Site Nottingham Maryland 21236
Pulmagen Investigational Site Plymouth Minnesota
Pulmagen Investigational Site Bellevue Nebraska 68123
Pulmagen Investigational Site Brick New Jersey
Pulmagen Investigatinal Site Clemmons North Carolina 27012
Pulmagen Investigational Site Canton Ohio
Pulamgen Investigational Site Cincinnati Ohio 45231
Pulmagen Investigational Site Maumee Ohio
Pulmagen Investigational Site Oklahoma City Oklahoma
Pulmagen Investigational Site Tulsa Oklahoma 74136
Pulmagen Investigational Site Medford Oregon
Pulmagen Investigational Site Portland Oregon
Pulmagen Investigational Site East Providence Rhode Island
Pulmagen Investigational Site Warwick Rhode Island 02886
Pulmagen Investigational Site Charleston South Carolina
Pulmagen Investigational Site Fort Mill South Carolina 29707
Pulmagen Investigational Site Arlington Texas
Pulmagen Investigational Site Austin Texas
Pulmagen Investigational Site Houston Texas 77099
Pulmagen Investigational Site Killeen Texas
Pulmagen Investigational Site Waco Texas
Pulmagen Investgational Site Woodway Texas 76712
Pulmagen Investigational Site Draper Utah
Pulmagen Investigational Site Seattle Washington
Pulmagen Investigational Site Tacoma Washington 98405
Pulmagen Investigational Site Greenfield Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01730027, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2017 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01730027 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →